Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative eltrombopag for inherited thrombocytopenia
2017-004489-88Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of eltrombopag in hereditary thrombocytopenia, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Full response. Started Dec 2017; status: completed.
02
Drugs
eltrombopag
03
Conditions
hereditary thrombocytopenia
Beyond the preview
Go deeper on 2017-004489-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004489-88.